-
Takeda Pharmaceuticals Fumarate Vonorasone Tablets Approved for New Indications to Eradicate Helicobacter pylori in China
On November 24th, Takeda Pharmaceuticals announced that a new indication for its innovative digestive product, Fumarate Vonorasone Tablets, has been approved by the National Medical Products Administ ...- suisuiblue
- 2023-11-24
- サポート
- に反対
- 返信
- コレクション
-
Pfizer: JAK1 inhibitor Xibico has been approved as a new indication for age expansion in China
Pfizer: JAK1 inhibitor Xibico has been approved as a new indication for age extension in China. Pfizer announced that the highly selective JAK1 inhibitor and innovative oral small molecule targeted d ... -
Novo Nordisk Smegglutide Approved for Cardiovascular Indications for the First Time
Recently, a new indication for the Novo Nordisk weight loss therapy Wegovy (Smegglutide) injection has been approved by the US FDA to reduce the risk of cardiovascular death, heart attack, and stroke ... -
The first PD-L1 inhibitor for the treatment of gastric cancer, Pfizer Zeteme, has been approved for its fifth indication
On March 15th, Pfizer announced that its innovative tumor immunotherapy drug, Serenigme (Shuglizumab Injection), has been approved by the National Medical Products Administration for first-line treat ...